Pharmacodynamic efficacy of IONIS-FB-LRX, a complement factor B antisense oligonucleotide, in a phase 1 clinical study
McCaleb, Michael, Hughes, Steve, Greary, Richard, Monia, Brett, Grossman, TamarТом:
102
Мова:
english
Журнал:
Molecular Immunology
DOI:
10.1016/j.molimm.2018.06.154
Date:
October, 2018
Файл:
PDF, 55 KB
english, 2018